Echo Therapeutics, Inc. Other Noncash Expense
Echo Therapeutics, Inc. reported Other Noncash Expense of $2.88 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2015-04-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2015-04-20
- Echo Therapeutics, Inc. other noncash expense for the quarter ending 2014-09-30 was $0.00.
- Echo Therapeutics, Inc. other noncash expense for the quarter ending 2014-06-30 was $0.00.
- Echo Therapeutics, Inc. other noncash expense for the quarter ending 2014-03-31 was $2.88M, a 0.00% change year-over-year.
- Echo Therapeutics, Inc. other noncash expense for the quarter ending 2013-12-31 was $0.00.
- Echo Therapeutics, Inc. other noncash expense for fiscal 2013 was $2.88M.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 6 month | Other Noncash Expense 9 month | Other Noncash Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-20 | $0.00 derived: sum of 2 quarters · filed 2015-04-20 | $2.88M 10-Q · filed 2015-04-20 | $2.88M derived: sum of 4 quarters · filed 2015-04-20 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $2.88M 10-Q · filed 2014-08-14 | $2.88M derived: sum of 3 quarters · filed 2014-08-14 | $2.88M derived: sum of 4 quarters · filed 2014-08-14 |
| 2014-03-31 | $2.88M 10-Q · filed 2014-05-12 | $2.88M derived: sum of 2 quarters · filed 2014-05-12 | $2.88M derived: sum of 3 quarters · filed 2014-05-12 | $2.88M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $2.88M 10-K · filed 2014-03-28 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $2.88M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.88M 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | $2.88M 10-Q · filed 2013-05-10 |